Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
All-oral treatment for treatment-naïve HCV genotype 3 in the Asian-Pacific Region
| Companies (regimen) [references] | Drug targets | Ribavirin | Duration of treatment (weeks) | SVR (%) | |
|---|---|---|---|---|---|
| NS5A | NS5B | ||||
| Gilead Sciences [68, 70, 71] | Sofosbuvir (400 mg daily) | + | 12 or 24 | 12 weeks Non-cirrhotic: 61–68 F4: 21–34 24 weeks Non-cirrhotic: 94 F4: 92 |
|
| Bristol-Myers Squibb [76] | Daclatasvir (60 mg daily) | Sofosbuvir (400 mg daily) | – | 12 | Non-cirrhotic: 97 F4: 58 |
